Cargando…
Genetic alterations in 47 patients with a novel myelodysplastic syndrome diagnosis at a single center
At least one mutation is present in 70–80% of patients with myelodysplastic syndrome (MDS). Genetic alterations and other molecular biological markers have been included in the diagnostic and treatment guidelines for MDS. The aim of the present study was to analyze the association between genetic al...
Autores principales: | Zhao, Pan, Qin, Jiayue, Liu, Weiyi, Quan, Richeng, Xiao, Haiyan, Liu, Chi, Li, Liu, Lv, Yan, Zhu, Qianze, Wang, Hongzhi, Guo, Xiaoqing, Wang, Juan, Hu, Xiaomei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781645/ https://www.ncbi.nlm.nih.gov/pubmed/31612018 http://dx.doi.org/10.3892/ol.2019.10853 |
Ejemplares similares
-
Using circulating tumor DNA to monitor myelodysplastic syndromes status
por: Zhao, Pan, et al.
Publicado: (2019) -
Cytogenetic characteristics of 665 patients with myelodysplastic syndrome in China: A single-center report
por: Wang, Xueying, et al.
Publicado: (2021) -
Predicting bleeding risk in a Chinese immune thrombocytopenia (ITP) population: development and assessment of a new predictive nomogram
por: Wang, Mingjing, et al.
Publicado: (2020) -
Comparison of the effects between MPL and JAK2V617F on thrombosis and peripheral blood cell counts in patients with essential thrombocythemia: a meta-analysis
por: Yang, Erpeng, et al.
Publicado: (2021) -
Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis
por: Wang, Ziqing, et al.
Publicado: (2021)